MedElevator Войти в исследования
← Поиск публикаций

DOI 10.21873/anticanres.17904

Медицинская библиотека · Anticancer research · 2025

Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures.

Kuo Jen-Hao, Ou Yin-Chien, Hu Che-Yuan, Wu Kuan-Yu, Liu Chan-Jung, Lu Ze-Hong, Jan Hau-Chern, Lin Kun-Che, Hsieh Yi-Chia, Ou Chien-Hui, Tsai Yuh-Shyan

СтатьяПеревод в очереди

Аннотация

BACKGROUND/AIM: Prostate cancer is a common malignancy among men. However, identifying clinically significant prostate cancer (csPCa) remains challenging, particularly in the Prostate Imaging Reporting and Data System (PI-RADS) 3-4 lesions. This study evaluated whether combining prostate-specific antigen (PSA)-derived biomarkers and clinical parameters with multiparametric magnetic resonance imaging (mpMRI) improves risk stratification and reduces unnecessary biopsies.

PATIENTS AND

METHODS

Comprehensive clinical data of 165 patients who underwent mpMRI and MRI-ultrasound fusion-guided prostate biopsy between 2021 and 2024 was retrospectively analyzed. Patients were stratified by PI-RADS scores into two groups: 3-4 and 5. csPCa was defined as International Society of Urological Pathology grade group 2 or higher. Logistic regression models were used to identify predictors of csPCa. The diagnostic utility of PI-RADS scores alone and in combination with PSA density and PSA velocity was evaluated through receiver operating characteristic curves and decision curve analysis (DCA).

RESULTS

csPCa was detected in 30.8% of PI-RADS 3-4 lesions. PSA density was identified as an independent predictor [odds ratio (OR)=2.301, p=0.034]. In the PI-RADS 3-4 subgroup, the combination of PSA density and PSA velocity achieved an area under the curve of 0.673. DCA showed that the combined model provided the highest net benefit within the 18%-50% threshold range, reducing unnecessary biopsies by 68.0% while missing 33.3% of csPCa cases.

CONCLUSION

Integrating PSA density and PSA velocity improves diagnostic performance in PI-RADS 3-4 lesions. This approach may assist in clinical decision-making by reducing over-biopsy while maintaining acceptable sensitivity for detecting csPCa.

Для цитирования: Kuo Jen-Hao, Ou Yin-Chien, Hu Che-Yuan, Wu Kuan-Yu, Liu Chan-Jung, Lu Ze-Hong, Jan Hau-Chern, Lin Kun-Che, Hsieh Yi-Chia, Ou Chien-Hui, Tsai Yuh-Shyan. Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures.. Anticancer research. 2025. DOI: 10.21873/anticanres.17904.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.